FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Equine Vet J / Spontaneous regression of equine sarcoids is an exceptional ...
Equine veterinary journal2026; doi: 10.1002/evj.70158

Spontaneous regression of equine sarcoids is an exceptional event.

Abstract: Sarcoids are benign, yet locally aggressive skin tumours that commonly affect horses and other equid species. The lesions are induced by bovine papillomavirus types 1, 2, and probably 13 in conjunction with other factors including trauma and a genetic predisposition. Although sarcoids have a substantial impact on the health and welfare of affected equids, information on the immune response to bovine papillomavirus infection and resulting sarcoids is limited. However, there is evidence that sarcoid disease is associated with an impaired immune response to bovine papillomavirus infection. This observation agrees with the common perception of sarcoids as persistent lesions. Contrary to this general view, there are reports on the spontaneous regression of skin tumours diagnosed as sarcoids, giving rise to the question whether sarcoids can self-resolve, and if so, under which circumstances. This review addresses this unresolved issue.
© 2026 The Author(s). Equine Veterinary Journal published by John Wiley & Sons Ltd on behalf of EVJ Ltd.
Get Full Text
Publication Date: 2026-03-11 PubMed ID: 41814482DOI: 10.1002/evj.70158Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Spontaneous regression of equine sarcoids, typically persistent skin tumors caused by bovine papillomavirus, is a rare occurrence. This review explores the conditions under which these tumors might self-resolve despite their usual persistence.

Overview of Equine Sarcoids

  • Equine sarcoids are benign but locally aggressive skin tumors primarily affecting horses and other equids.
  • The tumors are caused by infection with bovine papillomavirus (BPV) types 1, 2, and possibly 13.
  • Other contributing factors to sarcoid development include trauma and genetic susceptibility in the host animal.
  • Despite being benign, sarcoids can severely impact the health and welfare of the affected equids because of their growth and local invasiveness.

Immune Response to Bovine Papillomavirus and Sarcoids

  • Information about how the equine immune system responds to BPV infection and sarcoid formation is limited.
  • Evidence suggests that sarcoid disease is linked to an impaired immune response against the BPV infection.
  • This impaired immunity aligns with the common experience that sarcoids tend to persist rather than resolve spontaneously.

Spontaneous Regression of Sarcoids

  • Occasionally, sarcoids have been reported to undergo spontaneous regression, meaning they shrink or disappear without treatment.
  • Such cases are considered exceptional and are not the typical clinical presentation.
  • This phenomenon raises important questions about the biological mechanisms that might enable sarcoids to self-resolve.
  • The review explores under what circumstances spontaneous regression might occur, challenging the prevailing notion that sarcoids are invariably persistent.

Significance of the Review

  • Understanding spontaneous regression could provide insights into immune mechanisms that control or eliminate BPV infection and sarcoids.
  • This knowledge might contribute to developing better therapeutic approaches or preventive measures for sarcoids in horses.
  • The review calls attention to an unresolved issue in equine veterinary medicine and encourages further research on the immune response and tumor biology of sarcoids.

Cite This Article

APA
Brandt S. (2026). Spontaneous regression of equine sarcoids is an exceptional event. Equine Vet J. https://doi.org/10.1002/evj.70158

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English

Researcher Affiliations

Brandt, Sabine
  • Research Group Oncology, Centre of Equine Health and Research, Veterinary University, Vienna, Austria.

References

This article includes 75 references
  1. Campo MS. Introduction. .
  2. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005;32(Suppl 1):S7–S15.
  3. Campo MS. Bovine papillomavirus: old system, new lessons?. .
  4. Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR. The biology and life‐cycle of human papillomaviruses. Vaccine 2012;30(Suppl 5):F55–F70.
  5. Chambers G, Ellsmore VA, O'Brien PM, Reid SW, Love S, Campo MS. Association of bovine papillomavirus with the equine sarcoid. J Gen Virol 2003;84:1055–1062.
  6. Hainisch EK, Abel‐Reichwald H, Shafti‐Keramat S, Pratscher B, Corteggio A, Borzacchiello G. Potential of a BPV1 L1 VLP vaccine to prevent BPV1‐ or BPV2‐induced pseudo‐sarcoid formation and safety and immunogenicity of EcPV2 L1 VLPs in the horse. J Gen Virol 2016;98(2):230–241.
    doi: 10.1099/jgv.0.000673google scholar: lookup
  7. Shafti‐Keramat S, Schellenbacher C, Handisurya A, Christensen N, Reininger B, Brandt S. Bovine papillomavirus type 1 (BPV1) and BPV2 are closely related serotypes. Virology 2009;393:1–6.
  8. Borzacchiello G, Roperto F. Bovine papillomaviruses, papillomas and cancer in cattle. Vet Res 2008;39:45.
  9. Lunardi M, de Alcantara BK, Otonel RA, Rodrigues WB, Alfieri AF, Alfieri AA. Bovine papillomavirus type 13 DNA in equine sarcoids. J Clin Microbiol 2013;51:2167–2171.
  10. Cutarelli A, Buonavoglia A, Fusco G, Pellicano R, Napoletano M, Brandt S. Accurate identification of bovine deltapapillomavirus in equine sarcoids by ddPCR. Sci Rep 2025;15:29414.
  11. Carr EA, Theon AP, Madewell BR, Griffey SM, Hitchcock ME. Bovine papillomavirus DNA in neoplastic and nonneoplastic tissues obtained from horses with and without sarcoids in the western United States. Am J Vet Res 2001;62:741–744.
  12. Wobeser BK, Davies JL, Hill JE, Jackson ML, Kidney BA, Mayer MN. Epidemiology of equine sarcoids in horses in western Canada. Can Vet J 2010;51:1103–1108.
  13. Bogaert L, Martens A, Depoorter P, Gasthuys F. Equine sarcoids ‐ Part 1: clinical presentation and epidemiology. Vlaams Diergeneeskd Tijdschr 2008;77:2–9.
  14. Scott DW, Miller WH Jr. Sarcoid. .
  15. Ireland JL, Wylie CE, Collins SN, Verheyen KL, Newton JR. Preventive health care and owner‐reported disease prevalence of horses and ponies in Great Britain. Res Vet Sci 2013;95:418–424.
  16. Reid SWJ, Gettinby G, Fowler JN, Ikin P. Epidemiologic observations on sarcoids in a population of donkeys (Equus‐Asinus). Vet Rec 1994;134:207–211.
  17. Mele M, Gerber V, Straub R, Gaillard C, Jallon L, Burger D. Prevalence of hereditary diseases in three‐year‐old horses of the Freiberger breed. Schweiz Arch Tierheilkd 2007;149:151–159.
  18. Studer S, Gerber V, Straub R, Brehm W, Gaillard C, Luth A. Prevalence of hereditary diseases in three‐year‐old Swiss Warmblood horses. Schweiz Arch Tierheilkd 2007;149:161–171.
  19. Joch D. Sarkoiderkrankung in Bezug auf Alter, Rasse und Geschlecht. Master thesis, University of Veterinary Medicine, Vienna, Austria. 2018.
  20. Mohammed HO, Rebhun WC, Antczak DF. Factors associated with the risk of developing sarcoid tumours in horses. Equine Vet J 1992;24:165–168.
  21. Valentine BA. Survey of equine cutaneous neoplasia in the Pacific Northwest. J Vet Diagn Invest 2006;18:123–126.
  22. Nasir L, Reid SWJ. Bovine papillomaviruses and equine sarcoids. In: Campo MS, editor. Papillomavirus research: from natural history to vaccines and beyond. 1st ed. Norfolk, UK: Caister Academic Press; 2006. p. 389–397.
  23. Hainisch EK, Brandt S. Equine sarcoids. In: Robinson NE, Sprayberry KA, editors. Robinson's current therapy in equine medicine. 7th ed. St. Louis: Saunders Elsevier; 2015 Chapter 99.
  24. Haspeslagh M, Vlaminck LE, Martens AM. Treatment of sarcoids in equids: 230 cases (2008‐2013). J Am Vet Med Assoc 2016;249:311–318.
  25. Knottenbelt DC. Sarcoid. In: Knottenbelt DC, editor. Pascoe's principles and practice of equine dermatology. London, UK: Saunders Elsevier; 2009. p. 387–407.
  26. Knottenbelt DC. The equine sarcoid: why are there so many treatment options?. Vet Clin North Am Equine Pract 2019;35:243–262.
  27. Knottenbelt DC. A suggested clinical classification for the equine sarcoid. Clin Tech Equine Pract 2005;4:278–295.
  28. Knottenbelt DC, Kelly DF. The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974 to 1999. Vet Ophthalmol 2000;3:169–191.
  29. Berruex F, Gerber V, Wohlfender FD, Burger D, Koch C. Clinical course of sarcoids in 61 Franches‐Montagnes horses over a 5‐7 year period. Vet Q 2016;36:189–196.
  30. Amtmann E, Muller H, Sauer G. Equine connective tissue tumors contain unintegrated bovine papilloma virus DNA. J Virol 1980;35:962–964.
  31. Lancaster WD. Apparent lack of integration of bovine papillomavirus DNA in virus‐induced equine and bovine tumor cells and virus‐transformed mouse cells.. Virology 1981;108:251–255.
  32. Angelos JA, Marti E, Lazary S, Carmichael LE. Characterization of BPV‐like DNA in equine sarcoids.. Arch Virol 1991;119:95–109.
  33. Brandt S, Haralambus R, Shafti‐Keramat S, Steinborn R, Stanek C, Kirnbauer R. A subset of equine sarcoids harbours BPV‐1 DNA in a complex with L1 major capsid protein.. Virology 2008;375:433–441.
  34. Chow LT, Broker TR. Mechanisms and regulation of papillomavirus DNA replication.. 2006. p. 53–71.
  35. Howley PM, Lowy DR. Papillomaviruses and their replication.. 2001. p. 2197–2230.
  36. Nasir L, Brandt S. Papillomavirus associated diseases of the horse.. Vet Microbiol 2013;167:159–167.
  37. Nasir L, Campo MS. Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids.. Vet Dermatol 2008;19:243–254.
  38. Tong X, Howley PM. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton.. Proc Natl Acad Sci U S A 1997;94:4412–4417.
  39. Yuan Z, Gault EA, Campo MS, Nasir L. Different contribution of bovine papillomavirus type 1 oncoproteins to the transformation of equine fibroblasts.. J Gen Virol 2011;92:773–783.
  40. DeMasi J, Huh KW, Nakatani Y, Munger K, Howley PM. Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding.. Proc Natl Acad Sci U S A 2005;102:11486–11491.
  41. Wise‐Draper TM, Wells SI. Papillomavirus E6 and E7 proteins and their cellular targets.. Front Biosci 2008;13:1003–1017.
  42. Borzacchiello G. Bovine papillomavirus on the scene of crime: is E5 oncogene the only guilty party?. Infect Agent Cancer 2013;8:26.
  43. Borzacchiello G, Roperto F, Campo MS, Venuti A. 1st international workshop on papillomavirus E5 oncogene‐a report.. Virology 2010;408:135–137.
  44. Suprynowicz FA, Campo MS, Schlegel R. Biologic activities of papillomavirus E5 proteins.. 2006. p. 97–114.
  45. Knowles G, Grindlay GJ, Campo MS, Chandrachud LM, O'Neil BW. Linear B‐cell epitopes in the N‐terminus of L2 of bovine papillomavirus type 4.. Res Vet Sci 1997;62:289–291.
  46. Geisshusler H, Marti E, Stoffel MH, Kuhni K, Stojiljkovic A, von Tscharner C. Quantitative analysis of infiltrating immune cells and bovine papillomavirus type 1 E2‐positive cells in equine sarcoids.. Vet J 2016;216:45–52.
  47. Brandt S. Immune response to bovine papillomavirus type 1 in equine sarcoid.. Vet J 2016;216:107–108.
  48. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system.. Int Rev Immunol 2011;30:16–34.
  49. Stanley MA. Immunobiology of papillomavirus infections.. J Reprod Immunol 2001;52:45–59.
  50. Huang B, Zhao J, Li H, He KL, Chen Y, Chen SH. Toll‐like receptors on tumor cells facilitate evasion of immune surveillance.. Cancer Res 2005;65:5009–5014.
  51. Yuan ZQ, Nicolson L, Marchetti B, Gault EA, Campo MS, Nasir L. Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts.. J Virol 2008;82:6481–6491.
  52. Yuan ZQ, Bennett L, Campo MS, Nasir L. Bovine papillomavirus type 1 E2 and E7 proteins down‐regulate Toll Like Receptor 4 (TLR4) expression in equine fibroblasts.. Virus Res 2010;149:124–127.
  53. Janeway CAJ, Travers P, Walport M, Shlomchik MJ. The recognition and effector mechanisms of adaptive immunity.. 2005. p. 24–36.
  54. Stanley M. Immunobiology of papillomaviruses.. 2006. p. 311–319.
  55. Marchetti B, Gault EA, Cortese MS, Yuan Z, Ellis SA, Nasir L. Bovine papillomavirus type 1 oncoprotein E5 inhibits equine MHC class I and interacts with equine MHC I heavy chain.. J Gen Virol 2009;90:2865–2870.
  56. Ashrafi GH, Brown DR, Fife KH, Campo MS. Down‐regulation of MHC class I is a property common to papillomavirus E5 proteins.. Virus Res 2006;120:208–211.
  57. Olson C Jr, Cook RH. Cutaneous sarcoma‐like lesions of the horse caused by the agent of bovine papilloma.. Proc Soc Exp Biol Med 1951;77:281–284.
  58. Ragland WL, Spencer GR. Attempts to relate bovine papilloma virus to the cause of equine sarcoid: equidae inoculated intradermally with bovine papilloma virus.. Am J Vet Res 1969;30:743–752.
  59. Voss JL. Transmission of equine sarcoid.. Am J Vet Res 1969;30:183–191.
  60. Hartl B, Hainisch EK, Shafti‐Keramat S, Kirnbauer R, Corteggio A, Borzacchiello G. Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo‐sarcoid formation.. J Gen Virol 2011;92:2437–2445.
  61. Bogaert L, Martens A, Kast WM, Van Marck E, De Cock H. Bovine papillomavirus DNA can be detected in keratinocytes of equine sarcoid tumors.. Vet Microbiol 2010;146:269–275.
  62. Brandt S, Tober R, Corteggio A, Burger S, Sabitzer S, Walter I. BPV‐1 infection is not confined to the dermis but also involves the epidermis of equine sarcoids.. Vet Microbiol 2011;150:35–40.
  63. Wilson AD, Armstrong EL, Gofton RG, Mason J, De Toit N, Day MJ. Characterisation of early and late bovine papillomavirus protein expression in equine sarcoids.. Vet Microbiol 2013;162:369–380.
  64. Abel‐Reichwald H, Hainisch EK, Zahalka S, Corteggio A, Borzacchiello G, Massa B. Epidemiologic analysis of a sarcoid outbreak involving 12 of 111 donkeys in Northern Italy.. Vet Microbiol 2016;196:85–92.
  65. Finlay M, Yuan Z, Burden F, Trawford A, Morgan IM, Campo MS. The detection of bovine papillomavirus type 1 DNA in flies.. Virus Res 2009;144:315–317.
  66. Kemp‐Symonds JG. The detection and sequencing of bovine papillomavirus type 1 and 2 DNA from Musca autumnalis (Diptera: Muscidae) face flies infesting sarcoid‐affected horses.. 2000.
  67. Bogaert L, Martens A, De Baere C, Gasthuys F. Detection of bovine papillomavirus DNA on the normal skin and in the habitual surroundings of horses with and without equine sarcoids.. Res Vet Sci 2005;79:253–258.
  68. Hainisch EK, Jindra C, Reicher P, Miglinci L, Brodesser DM, Brandt S. Bovine papillomavirus type 1 or 2 Virion‐infected primary fibroblasts constitute a near‐natural equine sarcoid model.. Viruses 2022;14(12):2658.
    doi: 10.3390/v14122658google scholar: lookup
  69. Galloway DA. Human papillomaviruses: a growing field.. Genes Dev 2009;23:138–142.
  70. Giroglou T, Florin L, Schafer F, Streeck RE, Sapp M. Human papillomavirus infection requires cell surface heparan sulfate.. J Virol 2001;75:1565–1570.
  71. Patterson NA, Smith JL, Ozbun MA. Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate.. J Virol 2005;79:6838–6847.
  72. Brostrom H. Equine sarcoids. A clinical and epidemiological study in relation to equine leucocyte antigens (ELA).. Acta Vet Scand 1995;36:223–236.
  73. Cosandey J, Hamza E, Gerber V, Ramseyer A, Leeb T, Jagannathan V. Diagnostic and prognostic potential of eight whole blood microRNAs for equine sarcoid disease.. PLoS One 2021;16:e0261076.
  74. Christen‐Clottu O, Klocke P, Burger D, Straub R, Gerber V. Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (Viscum album austriacus).. J Vet Intern Med 2010;24:1483–1489.
  75. Haralambus R, Burgstaller J, Klukowska‐Rotzler J, Steinborn R, Buchinger S, Gerber V. Intralesional bovine papillomavirus DNA loads reflect severity of equine sarcoid disease.. Equine Vet J 2010;42:327–331.

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,000 horse owners like you who receive our email updates on horse health and nutrition.